DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

INSMED, INC. (NASDAQ: INSM)

18.54 0.38 (2.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INSM $18.54 2.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $18.04
Previous Close $18.16
Daily Range $17.53 - $18.85
52-Week Range $11.25 - $21.15
Market Cap $920.8M
P/E Ratio -9.51
Dividend (Yield) $0.00 (0.0%)
Volume 506,422
Average Daily Volume 396,250
Current FY EPS -$1.97

Sector

Healthcare

Industry

Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website: http://www.insmed.com/

News & Commentary Rss Feed

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape

Markets Rise; Macy's Lowers Comparable Sales Outlook

Markets Rise; Macy's Lowers Comparable Sales Outlook

Benzinga's Volume Movers

Sector Update: Health Care

See More INSM News...

INSM's Top Competitors

INSM $18.54 (2.09%)
Current stock: INSM
AMGN $157.72 (-0.79%)
Current stock: AMGN
GILD $103.53 (-0.63%)
Current stock: GILD
BIIB $409.59 (-0.12%)
Current stock: BIIB